Hydrogen-Generating Nanoparticles in Lab Tests Against Melanoma

A hydrogen-releasing zinc-based nanoparticle killed melanoma cells and boosted immune responses, especially when combined with checkpoint therapy.

A hydrogen-generating nanoparticle triggered cancer cell death and immune activation in melanoma models, with enhanced effects when combined with immune checkpoint blockade therapy.

Researchers developed a nanoparticle (tiny engineered particle) made from zinc-doped materials that generates hydrogen gas inside tumor cells. In laboratory and mouse studies, this nanoparticle created hydrogen gas and released zinc ions inside cancer cells, which disrupted the cells' ability to manage oxidative stress (an imbalance of harmful molecules), triggering the cancer cells to die in a way that activated the immune system. When combined with an immune checkpoint inhibitor drug, this approach extended survival and reduced tumor spread in melanoma-bearing mice.

This is early-stage laboratory and animal research on a specialized nanoparticle delivery system, not a study of hydrogen water or any product available to consumers. While the results in mice are promising for potential future cancer treatments, this work is far from human application and does not provide evidence about hydrogen water's effects on health or disease.

Abstract Hydrogen‐based tumor therapy demonstrates therapeutic potential, while the efficacy remains limited by insufficient intracellular hydrogen generation, poorly controlled release kinetics, and inadequate immune response potentiation. To address these limitations, a partially reduced…

Read the full abstract on PubMed